Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor.

Douglas G. Johns,Louis-Charles Campeau,Puja Banka,An Bautmans,Tjerk Bueters,Elisabetta Bianchi,Danila Branca,Paul G. Bulger, Inne Crevecoeur,Fa-Xiang Ding,Robert M. Garbaccio,Erik D. Guetschow, Yan Guo,Sookhee N. Ha,Jennifer M. Johnston,Hubert Josien,Eunkyung A. Kauh,Kenneth A. Koeplinger,Jeffrey T. Kuethe,Eseng Lai, Christine L. Lanning,Anita Y. H. Lee, Li,Anilkumar G. Nair,Edward A. O'Neill,S. Aubrey Stoch,David A. Thaisrivongs,Thomas J. Tucker,Petr Vachal,Kristien van Dyck,Frederic P. Vanhoutte,Bram Volckaert,Dennis G. Wolford, Andy Xu,Tian Zhao, Dan Zhou,Susan Zhou,Xiaohong Zhu,Hratch J. Zokian,Abbas M. Walji,Harold B. Wood

CIRCULATION（2023）

Cited 46|Views56
Key words
atherosclerosis,cholesterol,clinical trial,hypercholesterolemia,low density lipoprotein,macrocyclic peptide,mRNA display technology,PCSK9 inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined